Login / Signup

Intravenous cyclophosphamide therapy for patients with severe ocular inflammatory diseases who failed other immunomodulatory therapies.

Irmak KaracaElaine M TranSungWho ParkAlbert BromeoHassan KhojastehAnh Ngọc Tram TranNegin YavariAmir AkhavanrezayatCigdem YasarGunay Uludag KirimliNgoc Tuong Trong ThanMuhammad HassanChristopher OrHashem GhorabaDiana V DoQuan Dong Nguyen
Published in: Journal of ophthalmic inflammation and infection (2024)
CP therapy can be considered a potentially effective and relatively safe therapeutic option for patients with severe ocular inflammatory diseases who failed other IMTs including biologics (TNFa and CD20 inhibitors).
Keyphrases
  • high dose
  • oxidative stress
  • early onset
  • low dose
  • stem cells
  • drug induced
  • cell therapy
  • optical coherence tomography
  • chemotherapy induced